cost of glp 1 in canada semaglutide Novo cuts GLP-1 prices 70%, but semaglutide revenue could grow 2026 GLP-1 Drug Coverage in Canada
Description
A very timely and necessary intervention by regulators
*For weight loss-related consultation only
Analysis by MavenBio highlights that while other pharma companies have broad, diversified portfolios Lilly is the most concentrated large pharma companies: cardiometabolic therapies generated $13.8B, representing over 78% of total pharma revenue
Certainly, access to services is really important
You can start with a month to month prescription and budget for it monthly
